Index
RUT
P/E
-
EPS (ttm)
-1.63
Insider Own
0.69%
Shs Outstand
49.40M
Perf Week
30.42%
Market Cap
1.25B
Forward P/E
39.44
EPS next Y
0.64
Insider Trans
-
Shs Float
49.17M
Perf Month
46.31%
Enterprise Value
1.10B
PEG
-
EPS next Q
0.08
Inst Own
109.59%
Perf Quarter
13.61%
Income
-80.45M
P/S
5.21
EPS this Y
140.58%
Inst Trans
-2.12%
Perf Half Y
-5.65%
Sales
239.44M
P/B
3.62
EPS next Y
57.49%
ROA
-16.57%
Perf YTD
9.18%
Book/sh
6.97
P/C
6.66
EPS next 5Y
-
ROE
-21.70%
52W High
30.81 -18.18%
Perf Year
58.85%
Cash/sh
3.79
P/FCF
-
EPS past 3/5Y
- -
ROIC
-21.36%
52W Low
14.69 71.61%
Perf 3Y
-59.65%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-5.57% 7.93%
Gross Margin
74.01%
Volatility
5.65% 5.69%
Perf 5Y
-78.26%
Dividend TTM
-
EV/Sales
4.59
EPS Y/Y TTM
-296.85%
Oper. Margin
-20.26%
ATR (14)
1.33
Perf 10Y
227.40%
Dividend Ex-Date
-
Quick Ratio
3.74
Sales Y/Y TTM
-23.72%
Profit Margin
-33.60%
RSI (14)
77.71
Dividend Gr. 3/5Y
- -
Current Ratio
4.55
EPS Q/Q
47.04%
SMA20
31.08%
Beta
1.04
Payout
-
Debt/Eq
0.11
Sales Q/Q
18.08%
SMA50
35.57%
Rel Volume
4.08
Prev Close
20.88
Employees
957
LT Debt/Eq
0.09
SMA200
10.76%
Avg Volume
1.43M
Price
25.21
IPO
Jul 07, 1983
Option/Short
Yes / Yes
Trades
Volume
5,575,159
Change
20.74%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-09-26 Upgrade
Canaccord Genuity
Hold → Buy
$27
Feb-03-26 Initiated
Wedbush
Neutral
$26
Jan-16-26 Resumed
Morgan Stanley
Underweight
$13
Apr-21-25 Initiated
Wells Fargo
Equal Weight
$17
Feb-12-25 Downgrade
William Blair
Outperform → Mkt Perform
Feb-12-25 Downgrade
Mizuho
Outperform → Neutral
$45 → $17
Feb-12-25 Downgrade
Jefferies
Buy → Hold
Feb-12-25 Downgrade
BTIG Research
Buy → Neutral
Jul-15-24 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$50 → $37
Jun-11-24 Upgrade
BTIG Research
Neutral → Buy
$46
Mar-11-24 Upgrade
Stifel
Hold → Buy
$30 → $50
Dec-05-23 Downgrade
Needham
Buy → Hold
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$35
Sep-15-23 Downgrade
The Benchmark Company
Buy → Hold
Aug-03-23 Downgrade
Canaccord Genuity
Buy → Hold
$77 → $48
Jun-07-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-17-23 Initiated
Piper Sandler
Neutral
$65
Feb-06-23 Downgrade
BTIG Research
Buy → Neutral
Dec-28-22 Reiterated
BTIG Research
Buy
$80 → $67
Dec-08-22 Initiated
Stifel
Hold
$60
Show Previous Ratings
Apr-09-26 01:32PM
06:26AM
Apr-08-26 04:01PM
Mar-17-26 06:57AM
Mar-04-26 08:30AM
12:02AM
Loading…
12:02AM
Mar-03-26 07:02PM
05:15PM
04:34PM
04:21PM
(Associated Press Finance)
04:02PM
04:01PM
Mar-02-26 09:36AM
Feb-26-26 05:30PM
Feb-25-26 04:01PM
12:31PM
Loading…
Feb-24-26 12:31PM
08:31AM
Feb-23-26 04:01PM
08:46AM
08:45AM
Feb-19-26 12:08PM
Feb-18-26 05:18AM
Feb-17-26 04:01PM
Feb-09-26 11:37PM
Feb-05-26 10:00AM
07:55AM
Feb-04-26 01:27PM
Feb-03-26 10:00AM
09:34AM
05:23AM
12:55PM
Loading…
Feb-02-26 12:55PM
07:00AM
Jan-30-26 01:00PM
Jan-25-26 08:18PM
Jan-23-26 04:35PM
Jan-16-26 08:39PM
09:32AM
08:02AM
05:00AM
Jan-15-26 11:04PM
01:06PM
08:30AM
Jan-13-26 08:45AM
Jan-07-26 07:38AM
Jan-06-26 08:00PM
12:32PM
(The Wall Street Journal)
12:14PM
09:52AM
08:47AM
06:13AM
Dec-19-25 03:51PM
12:59PM
11:45AM
Dec-17-25 06:47PM
04:53PM
01:17PM
10:55AM
Dec-16-25 03:58PM
01:32PM
09:12AM
07:00AM
Dec-15-25 06:35PM
Dec-12-25 05:29PM
08:40AM
Dec-11-25 08:06PM
11:41AM
09:47AM
07:00AM
Dec-10-25 01:34PM
07:05AM
Dec-09-25 02:25PM
02:16PM
12:39PM
12:00PM
08:30AM
Dec-08-25 04:11PM
01:28PM
08:16AM
08:00AM
Dec-04-25 10:35PM
Dec-03-25 12:02PM
Dec-02-25 04:14PM
Nov-26-25 03:34PM
Nov-18-25 04:15PM
Nov-12-25 02:35PM
Nov-10-25 06:38PM
01:00PM
08:00AM
Nov-07-25 04:22PM
10:10AM
Nov-06-25 06:21AM
Nov-05-25 04:27PM
(Associated Press Finance)
04:01PM
Nov-04-25 11:32PM
03:13PM
11:52AM
01:00AM
Oct-31-25 12:00PM
11:14AM
Oct-27-25 04:43PM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Foust Warren Interim Co-CEO and Pres. & COO Mar 14 '26 Option Exercise 0.00 29,325 0 63,588 Mar 16 05:00 PM Foust Warren Interim Co-CEO and Pres. & COO Mar 12 '26 Option Exercise 0.00 8,175 0 34,263 Mar 16 05:00 PM Michna Magda Chief Development Officer Mar 14 '26 Option Exercise 0.00 17,595 0 36,001 Mar 16 05:00 PM Michna Magda Chief Development Officer Mar 12 '26 Option Exercise 0.00 6,178 0 20,622 Mar 16 05:00 PM BROADWOOD PARTNERS, L.P. Director Mar 13 '26 Buy 18.61 316,017 5,882,656 16,123,842 Mar 13 07:59 PM BROADWOOD PARTNERS, L.P. Director Mar 12 '26 Buy 18.12 299,432 5,424,330 15,807,825 Mar 13 07:59 PM BROADWOOD PARTNERS, L.P. Director Mar 11 '26 Buy 17.52 54,764 959,558 15,508,393 Mar 13 07:59 PM Jiang Wei Director Jan 12 '26 Option Exercise 0.00 20,967 0 66,444 Jan 14 05:48 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 09 '26 Buy 22.05 27,485 606,138 15,453,629 Jan 13 09:30 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 06 '26 Buy 21.62 336,946 7,284,281 15,356,437 Jan 08 07:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 07 '26 Buy 22.00 66,467 1,462,301 15,422,904 Jan 08 07:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 08 '26 Buy 21.94 3,240 71,082 15,426,144 Jan 08 07:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 21 '25 Buy 27.86 797,486 22,218,837 15,019,491 Nov 21 09:55 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 20 '25 Buy 27.14 393,382 10,675,325 14,222,005 Nov 21 09:55 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 19 '25 Buy 26.42 309,132 8,166,155 13,828,623 Nov 21 09:55 PM Jiang Wei Director Nov 12 '25 Option Exercise 0.00 20,967 0 45,477 Nov 14 06:00 PM Jiang Wei Director Aug 12 '25 Option Exercise 0.00 20,967 0 24,510 Aug 13 06:39 PM WEISNER AIMEE S Former Director Aug 05 '25 Proposed Sale 26.87 1,750 47,025 Aug 05 06:38 PM WEISNER AIMEE S Former Director Aug 05 '25 Proposed Sale 26.87 13,491 362,523 Aug 05 06:33 PM